TRIDEK-ONE
Tridek is a developer of immunomodulatory products intended for moderating overactive responses without blockade. The company's product is a peptide which maintains cluster of truncated CD31 to the membrane for a diversity of auto-immune and inflammatory disorders, enabling medical companies to treat their patients with better drugs and give them a better life.
TRIDEK-ONE
Industry:
Biotechnology Life Science
Founded:
1978-01-01
Address:
Évry, Ile-de-France, France
Country:
France
Website Url:
http://www.tridekone.com
Total Employee:
1+
Status:
Active
Total Funding:
3 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Current Employees Featured
Founder
Investors List
Advent Life Sciences
Advent Life Sciences investment in Venture Round - Tridek-One
AdBio partners
AdBio partners investment in Venture Round - Tridek-One
Official Site Inspections
http://www.tridekone.com
- Host name: cluster030.hosting.ovh.net
- IP address: 145.239.37.162
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
